Summary by Futu AI
LILLY ENDOWMENT INC, a reporting entity associated with Eli Lilly and Co (LLY), completed a significant sale of Eli Lilly's common stock on June 10, 2024. The transactions were executed in the open market, with a total of 75,510 shares sold. Prices per share ranged from $851.688 to $870.13, resulting in an aggregate market value of approximately $64,997,274. Following the sales, LILLY ENDOWMENT INC's direct holdings in Eli Lilly amounted to 97,793,810 shares of common stock. The sales occurred in a single day, indicating a substantial change in the endowment's investment in the pharmaceutical company.